Amneal Pharmaceuticals (AMRX) EBITDA Margin (QoQ) (2017 - 2026)
Powered by 
Analysis
Amneal Pharmaceuticals (AMRX) EBITDA Margin (QoQ) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 171.02 Mn | 171.02 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -332.00 |
| Mar 31, 2026 | 586.00 |
| Dec 31, 2025 | 479.00 |
| Sep 30, 2025 | -641.00 |
| Jun 30, 2025 | 94.00 |
| Mar 31, 2025 | 405.00 |
| Dec 31, 2024 | -227.00 |
| Sep 30, 2024 | -96.00 |
| Jun 30, 2024 | 1,523.00 |
| Mar 31, 2024 | -393.00 |
| Dec 31, 2023 | -990.00 |
| Sep 30, 2023 | -117.00 |
| Jun 30, 2023 | 719.00 |
| Mar 31, 2023 | 27.00 |
| Dec 31, 2022 | -222.00 |
| Sep 30, 2022 | 4,364.00 |
| Jun 30, 2022 | -4,019.00 |
| Mar 31, 2022 | 260.00 |
| Dec 31, 2021 | -331.00 |
| Sep 30, 2021 | -715.00 |